{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:13:14Z","timestamp":1793661194182,"version":"4.5.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,30]],"date-time":"2015-04-30T00:00:00Z","timestamp":1430352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["84733"],"award-info":[{"award-number":["84733"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000278","name":"Department for International Development, UK Government","doi-asserted-by":"publisher","award":["MR\/K000500\/1"],"award-info":[{"award-number":["MR\/K000500\/1"]}],"id":[{"id":"10.13039\/501100000278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["31003A_135746"],"award-info":[{"award-number":["31003A_135746"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["100320\/Z\/12\/Z"],"award-info":[{"award-number":["100320\/Z\/12\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.ijpddr.2015.04.002","type":"journal-article","created":{"date-parts":[[2015,5,7]],"date-time":"2015-05-07T08:46:11Z","timestamp":1430988371000},"page":"65-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Chimerization at the AQP2\u2013AQP3 locus is the genetic basis of melarsoprol\u2013pentamidine cross-resistance in clinical Trypanosoma brucei gambiense isolates"],"prefix":"10.1016","volume":"5","author":[{"given":"Fabrice E.","family":"Graf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane C.","family":"Munday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry P.","family":"de Koning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5173-9284","authenticated-orcid":false,"given":"David","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"M\u00e4ser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2015.04.002_bib0010","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.molbiopara.2005.08.009","article-title":"Tagging a T.\u00a0brucei RRNA locus improves stable transfection efficiency and circumvents inducible expression position effects","volume":"144","author":"Alsford","year":"2005","journal-title":"Mol. Biochem. Parasitol"},{"key":"10.1016\/j.ijpddr.2015.04.002_bib0015","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1101\/gr.115089.110","article-title":"High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome","volume":"21","author":"Alsford","year":"2011","journal-title":"Genome Res"},{"key":"10.1016\/j.ijpddr.2015.04.002_bib0020","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature10771","article-title":"High-throughput decoding of antitrypanosomal drug efficacy and resistance","volume":"482","author":"Alsford","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2015.04.002_bib0025","doi-asserted-by":"crossref","first-page":"10996","DOI":"10.1073\/pnas.1202885109","article-title":"Aquaglyceroporin 2 controls susceptibility to melarsoprol and pentamidine in African trypanosomes","volume":"109","author":"Baker","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ijpddr.2015.04.002_bib0030","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.pt.2012.12.005","article-title":"Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story","volume":"29","author":"Baker","year":"2013","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.ijpddr.2015.04.002_bib0035","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0140-6736(09)60829-1","article-title":"Human African trypanosomiasis","volume":"375","author":"Brun","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2015.04.002_bib0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/361173a0","article-title":"Arsenical-resistant trypanosomes lack an unusual adenosine transporter","volume":"361","author":"Carter","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2015.04.002_bib0045","doi-asserted-by":"crossref","first-page":"28153","DOI":"10.1074\/jbc.270.47.28153","article-title":"Uptake of diamidine drugs by the P2 nucleoside transporter in melarsen-sensitive and -resistant Trypanosoma brucei brucei","volume":"270","author":"Carter","year":"1995","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.ijpddr.2015.04.002_bib0050","doi-asserted-by":"crossref","first-page":"e2475","DOI":"10.1371\/journal.pntd.0002475","article-title":"Aquaporin 2 mutations in Trypanosoma brucei gambiense field isolates correlate with decreased susceptibility to pentamidine and melarsoprol","volume":"7","author":"Graf","year":"2013","journal-title":"PLoS Negl. Trop. Dis"},{"key":"10.1016\/j.ijpddr.2015.04.002_bib0055","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1371\/journal.pntd.0000523","article-title":"Genotypic status of the TbAT1\/P2 adenosine transporter of Trypanosoma brucei gambiense isolates from Northwestern Uganda following melarsoprol withdrawal","volume":"3","author":"Kazibwe","year":"2009","journal-title":"PLoS Negl. Trop. Dis"},{"key":"10.1016\/j.ijpddr.2015.04.002_bib0060","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.actatropica.2007.07.007","article-title":"Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate","volume":"104","author":"Maina","year":"2007","journal-title":"Acta Trop"},{"key":"10.1016\/j.ijpddr.2015.04.002_bib0065","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0166-6851(01)00332-2","article-title":"Genetic variants of the TbAT1 adenosine transporter from African trypanosomes in relapse infections following melarsoprol therapy","volume":"117","author":"Matovu","year":"2001","journal-title":"Mol. Biochem. Parasitol"},{"key":"10.1016\/j.ijpddr.2015.04.002_bib0070","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1128\/EC.2.5.1003-1008.2003","article-title":"Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei","volume":"2","author":"Matovu","year":"2003","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.ijpddr.2015.04.002_bib0075","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.285.5425.242","article-title":"A nucleoside transporter from Trypanosoma brucei involved in drug resistance","volume":"285","author":"M\u00e4ser","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2015.04.002_bib0080","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.coph.2012.05.001","article-title":"Antiparasitic agents: new drugs on the horizon","volume":"12","author":"M\u00e4ser","year":"2012","journal-title":"Curr. Opin. Pharmacol"},{"key":"10.1016\/j.ijpddr.2015.04.002_bib0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1172\/JCI2605","article-title":"An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex","volume":"102","author":"Mulders","year":"1998","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.ijpddr.2015.04.002_bib0090","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/jac\/dkt442","article-title":"Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs","volume":"69","author":"Munday","year":"2014","journal-title":"J. Antimicrob. Chemother"},{"key":"10.1016\/j.ijpddr.2015.04.002_bib0095","doi-asserted-by":"crossref","first-page":"e3212","DOI":"10.1371\/journal.pntd.0003212","article-title":"Melarsoprol sensitivity profile of Trypanosoma brucei gambiense isolates from cured and relapsed sleeping sickness patients from the Democratic Republic of the Congo","volume":"8","author":"Pyana","year":"2014","journal-title":"PLoS Negl. Trop. Dis"},{"key":"10.1016\/j.ijpddr.2015.04.002_bib0100","doi-asserted-by":"crossref","first-page":"e1025","DOI":"10.1371\/journal.pntd.0001025","article-title":"Isolation of Trypanosoma brucei gambiense from cured and relapsed sleeping sickness patients and adaptation to laboratory mice","volume":"5","author":"Pyana","year":"2011","journal-title":"PLoS Negl. Trop. Dis"},{"key":"10.1016\/j.ijpddr.2015.04.002_bib0105","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.meegid.2014.12.017","article-title":"Population genetics of Trypanosoma brucei gambiense in sleeping sickness patients with treatment failures in the focus of Mbuji-Mayi, Democratic Republic of the Congo","volume":"30","author":"Pyana","year":"2015","journal-title":"Infect. Genet. Evol"},{"key":"10.1016\/j.ijpddr.2015.04.002_bib0110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.molbiopara.2010.09.002","article-title":"Genome-wide RNAi screens in bloodstream form trypanosomes identify drug transporters","volume":"175","author":"Schumann Burkard","year":"2011","journal-title":"Mol. Biochem. Parasitol"}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320715000081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320715000081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:44:44Z","timestamp":1761921884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320715000081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S2211320715000081"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2015.04.002","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chimerization at the AQP2\u2013AQP3 locus is the genetic basis of melarsoprol\u2013pentamidine cross-resistance in clinical Trypanosoma brucei gambiense isolates","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2015.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}